Logo image of HSON

HUDSON GLOBAL INC (HSON) Stock Fundamental Analysis

USA - NASDAQ:HSON - US4437872058 - Common Stock

9.875 USD
+0.01 (+0.05%)
Last: 9/4/2025, 8:12:14 PM
10.25 USD
+0.38 (+3.8%)
After Hours: 9/4/2025, 8:12:14 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HSON. HSON was compared to 86 industry peers in the Professional Services industry. HSON has a great financial health rating, but its profitability evaluates not so good. HSON has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HSON had negative earnings in the past year.
In the past year HSON had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HSON reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: HSON reported negative operating cash flow in multiple years.
HSON Yearly Net Income VS EBIT VS OCF VS FCFHSON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of HSON (-6.95%) is worse than 73.49% of its industry peers.
With a Return On Equity value of -9.72%, HSON is not doing good in the industry: 69.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.95%
ROE -9.72%
ROIC N/A
ROA(3y)1.69%
ROA(5y)1.53%
ROE(3y)2.69%
ROE(5y)2.54%
ROIC(3y)N/A
ROIC(5y)N/A
HSON Yearly ROA, ROE, ROICHSON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

HSON's Gross Margin of 51.77% is fine compared to the rest of the industry. HSON outperforms 65.06% of its industry peers.
HSON's Gross Margin has improved in the last couple of years.
HSON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
HSON Yearly Profit, Operating, Gross MarginsHSON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

HSON does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSON has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSON has less shares outstanding
There is no outstanding debt for HSON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HSON Yearly Shares OutstandingHSON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
HSON Yearly Total Debt VS Total AssetsHSON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

HSON has an Altman-Z score of -6.47. This is a bad value and indicates that HSON is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.47, HSON is doing worse than 89.16% of the companies in the same industry.
There is no outstanding debt for HSON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -6.47
ROIC/WACCN/A
WACC8.7%
HSON Yearly LT Debt VS Equity VS FCFHSON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.07 indicates that HSON has no problem at all paying its short term obligations.
HSON's Current ratio of 3.07 is amongst the best of the industry. HSON outperforms 85.54% of its industry peers.
HSON has a Quick Ratio of 3.07. This indicates that HSON is financially healthy and has no problem in meeting its short term obligations.
HSON has a better Quick ratio (3.07) than 86.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
HSON Yearly Current Assets VS Current LiabilitesHSON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for HSON have decreased strongly by -85.71% in the last year.
HSON shows a decrease in Revenue. In the last year, the revenue decreased by -3.26%.
The Revenue has been growing by 8.35% on average over the past years. This is quite good.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
Revenue 1Y (TTM)-3.26%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-0.48%

3.2 Future

The Earnings Per Share is expected to grow by 66.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 33.11% on average over the next years. This is a very strong growth
EPS Next Y63.2%
EPS Next 2Y66.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.91%
Revenue Next 2Y33.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HSON Yearly Revenue VS EstimatesHSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
HSON Yearly EPS VS EstimatesHSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HSON. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.00, the valuation of HSON can be described as reasonable.
HSON's Price/Forward Earnings ratio is rather cheap when compared to the industry. HSON is cheaper than 91.57% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, HSON is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8
HSON Price Earnings VS Forward Price EarningsHSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HSON is valued a bit cheaper than the industry average as 75.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.45
EV/EBITDA N/A
HSON Per share dataHSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HSON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HSON's earnings are expected to grow with 66.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUDSON GLOBAL INC

NASDAQ:HSON (9/4/2025, 8:12:14 PM)

After market: 10.25 +0.38 (+3.8%)

9.875

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners55.83%
Inst Owner Change0%
Ins Owners14.55%
Ins Owner Change64.48%
Market Cap34.56M
Analysts82.86
Price Target17.34 (75.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-362.62%
Min EPS beat(2)-463.72%
Max EPS beat(2)-261.52%
EPS beat(4)0
Avg EPS beat(4)-250.07%
Min EPS beat(4)-463.72%
Max EPS beat(4)-22.55%
EPS beat(8)1
Avg EPS beat(8)-390.31%
EPS beat(12)1
Avg EPS beat(12)-278.44%
EPS beat(16)5
Avg EPS beat(16)-190.57%
Revenue beat(2)1
Avg Revenue beat(2)-1.03%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)1.36%
Revenue beat(4)1
Avg Revenue beat(4)-8.45%
Min Revenue beat(4)-20.37%
Max Revenue beat(4)1.36%
Revenue beat(8)1
Avg Revenue beat(8)-8.23%
Revenue beat(12)1
Avg Revenue beat(12)-8.3%
Revenue beat(16)5
Avg Revenue beat(16)-4.37%
PT rev (1m)-10.53%
PT rev (3m)-10.53%
EPS NQ rev (1m)383.33%
EPS NQ rev (3m)383.33%
EPS NY rev (1m)-1.79%
EPS NY rev (3m)-338.46%
Revenue NQ rev (1m)28.05%
Revenue NQ rev (3m)28.05%
Revenue NY rev (1m)26.51%
Revenue NY rev (3m)26.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8
P/S 0.25
P/FCF 13.45
P/OCF 13.24
P/B 0.84
P/tB 1.04
EV/EBITDA N/A
EPS(TTM)-1.3
EYN/A
EPS(NY)1.23
Fwd EY12.5%
FCF(TTM)0.73
FCFY7.44%
OCF(TTM)0.75
OCFY7.55%
SpS39.52
BVpS11.71
TBVpS9.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.95%
ROE -9.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.77%
FCFM 1.86%
ROA(3y)1.69%
ROA(5y)1.53%
ROE(3y)2.69%
ROE(5y)2.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
F-Score5
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 3.31%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z -6.47
F-Score5
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)14.84%
Cap/Depr(5y)20.46%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.33%
EPS Next Y63.2%
EPS Next 2Y66.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.26%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-0.48%
Revenue Next Year21.91%
Revenue Next 2Y33.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.16%
OCF growth 3YN/A
OCF growth 5YN/A